$2.67 -$0.05 (-1.8%)

08:00 PM EDT on 07/02/20

Athersys, Inc. (NASDAQ:ATHX)

CAPS Rating: 1 out of 5

Current Price $2.67 Mkt Cap $525.4M
Open $0.00 P/E Ratio 0.00
Prev. Close $2.67 Div. (Yield) $0.00 (0.0%)
Daily Range $0.00 - $0.00 Volume 2,555,813
52-Wk Range $1.13 - $4.38 Avg. Daily Vol. 4,921,683

Caps

How do you think NASDAQ:ATHX will perform against the market?

Add Stock to CAPS Watchlist

All Players

85 Outperform
18 Underperform
 

All-Star Players

9 Outperform
10 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:ATHX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Dublin43016 (< 20)
Submitted February 22, 2014

1. Recent regulatory changes to accelerate regenerative medicine use in Japan, will allow faster development of their products. CEO has already made several trips so as to get his ducks in a row.2.Second quarter results on phase II study on… More

SmartAce (99.98)
Submitted October 02, 2018

The most unrealistic thing I've ever seen in a movie is when an entire family sits down to eat breakfast together on a weekday.

NASDAQ:ATHX VS S&P 500 (SPY)

Fools bullish on NASDAQ:ATHX are also bullish on:

Recent Community Commentary

Read the most recent pitches from players about ATHX.

Recs

0
Member Avatar naysaySA (56.13) Submitted: 6/18/2020 8:26:04 PM : Underperform Start Price: $2.84 NASDAQ:ATHX Score: +7.23

Chosen by Seeking Alpha author .Croatoan Capital as a long. Therefore, I short.

Recs

0
Member Avatar jw2net (< 20) Submitted: 2/19/2016 11:33:47 AM : Outperform Start Price: $1.64 NASDAQ:ATHX Score: +0.33

athx

Recs

0
Member Avatar zzlangerhans (99.10) Submitted: 2/3/2016 3:56:25 PM : Underperform Start Price: $1.28 NASDAQ:ATHX Score: -43.59

Nothing new from my last red thumb except an inexplicable price rebound despite a crashing sector, so I'll repost my last pitch.

I just wasted close to an hour trying to translate pages of handwaving from the last Athersys conference call into actionable information. My takeaway: I'm supposed to ignore all the negative developments over the last few years with MultiStem because cytokines. Add this to the company's recent Enjo Kosai activities with various small Japanese pharmas and we have a market cap of 104M, cash of about 40M (inclusive of Healios upfront payment), and a probable inert stem cell soup therapy. Athersys share price is holding up while former darlings StemCells, Caladrius, and Pluristem are going down the toilet but don't expect that to last long as spec biotech remains volatile and new positive catalysts fail to appear during the year.

Leaderboard

Find the members with the highest scoring picks in ATHX.

Score Leader

drugtrader

drugtrader (89.02) Score: +378.33

The Score Leader is the player with the highest score across all their picks in ATHX.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
Billdo2211 87.80 12/8/2011 Underperform 3M $2.24 +19.20% +148.99% +129.79 0 Comment
kevrose31 79.01 1/10/2014 Underperform 1Y $4.08 -34.56% +69.51% +104.07 0 Comment
Halffrenzy 24.86 2/28/2014 Underperform 5Y $3.87 -31.01% +66.84% +97.84 0 Comment
Under5 45.69 2/6/2017 Outperform 5Y $1.16 +130.17% +36.24% +93.93 0 Comment
Playa14 < 20 10/13/2015 Outperform 5Y $1.12 +138.39% +55.40% +82.99 0 Comment
Playa15 < 20 1/14/2016 Outperform 5Y $1.13 +136.28% +63.42% +72.86 0 Comment
GeneB43251 48.16 8/7/2015 Outperform 3Y $1.22 +118.85% +49.89% +68.97 0 Comment
z28quik < 20 4/27/2015 Outperform 3M $1.25 +114.46% +47.55% +66.91 0 Comment
7sins 22.92 4/27/2015 Outperform 5Y $1.26 +111.89% +47.01% +64.88 0 Comment
portefeuille 99.05 4/29/2019 Outperform 5Y $1.61 +65.84% +6.23% +59.61 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for ATHX.